.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Poster Session

Poster Session I (continued)

odd poster ID´s

Termin

Datum: Mo, 27.05.2024

Zeit: 20:00 – 21:30

Ort / Stream:

Meitner-Saal I+II & Planck-Lobby

Programm

Poster presentation
P063
Serological and molecular survey of Toxoplasma gondii infection in wild carnivores of the Iberian Peninsula
Martha Ynés Salas-Fajardo (Madrid / ES)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P065
Persistence of viable Toxoplasma gondii oocysts in Pacific oysters (Crassostrea gigas)
Lezlie Rueda (Davis / US)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P067
FACS-based CRISPR knockout screen identifies interferon stimulated genes that control Toxoplasma in pig cells
Dr. Marzuq Ungogo (Edinburgh / GB)
Host-Parasite Interaction & Signalling
Poster presentation
P069
Commercial kitten moist food inactivated Toxoplasma gondii tissue cysts instantaneously
Professor Andreas Lazaros Chryssafidis (Lages-SC / BR)
Metabolism, Biochemistry & Drug Development
Poster presentation
P071
Investigating contamination of ready-to-eat salads with Toxoplasma gondii oocysts in a European-wide multicenter survey
Professor Rafael Calero-Bernal (Madrid / ES)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P073
MyoJ-BCC1-Cen2: is there a contractile ring at the basal pole of Toxoplasma gondii?
Dr. Chloé Roumégous (Bordeaux / FR)
Cell Biology
Poster presentation
P075
Latent cerebral T. gondii infection exacerbates Tauopathy in a mouse model of Alzheimer"s disease.
Dr. Sabrina Marion (Lille / FR)
Immunology of Acute & Chronic Infection
Poster presentation
P077
Cooperation or Competition? Unraveling the interplay between transcription and epigenetic factors in Toxoplasma gondii gene expression
Dr. Marc-Jan Gubbels (Brighton / US)
Genomics
Poster presentation
P079
Relationships of MicroRNA 511_5p and ocular clinical characteristics in patients with ocular toxoplasmosis
Professor Danilo Donizete da Silva (São José do Rio Preto / BR)
Immunology of Acute & Chronic Infection
Poster presentation
P081
Redefining the role of latency during chronic Toxoplasma gondii infection in the central nervous system
Julia Eberhard (Philadelphia / US)
Immunology of Acute & Chronic Infection
Poster presentation
P083
Cross-talk between lipid metabolism, stress response and Toxoplasma gondii infection in dendritic cells.
Dr. Rémi Mascarau (Lille / FR)
Host-Parasite Interaction & Signalling
Poster presentation
P085
CRISPR/Cas9 screens for the identification of essential host factors for Toxoplasma gondii infection
Andrea Gaspare Valenti (Bern / CH)
Host-Parasite Interaction & Signalling
Poster presentation
P087
First data of Toxoplasma gondii genotyping from animals in Ukraine
Dr. Maryna Galat (Bern / CH)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P089
Human MHC Class I Molecule, HLA-A2.1, Medicates Activation of CD8+ T cell IFN-g Production and the T cell-Dependent Protection against Reactivation of Cerebral Toxoplasma Infection
Dr. Rajesh Mani (Lexington, VT / US)
Immunology of Acute & Chronic Infection
Poster presentation
P091
Characterization of a Lanthionine-Synthetase C in Toxoplasma
Swaroop Peddiraju (Hyderabad / IN)
Host-Parasite Interaction & Signalling
Poster presentation
P093
Investigating the response to iron deprivation in Toxoplasma
Dr. Jack Hanna (Glasgow / GB)
Cell Biology
Poster presentation
P095
Toxoplasma CRMPs: microneme sensors specifically devoted to rhoptry secretion
Dr. Daniela Sparvoli (Montpellier / FR)
Cell Biology
Poster presentation
P097
2,3-dihydro-1,4-benzodioxins are potent inhibitors of T. gondii tachyzoite regrowth in vitro
Dr. P. Holland Alday (Portland / US)
Metabolism, Biochemistry & Drug Development
Poster presentation
P099
Biochemical and Molecular Elucidation of Hydroquinine Mechanism(s) of Action against T. gondii
Professor Daniel A. Abugri (Montgomery / US)
Metabolism, Biochemistry & Drug Development
Poster presentation
P101
RNA triphosphatase-mediated mRNA capping is essential for maintaining transcriptome homeostasis and the survival of Toxoplasma gondii
Kalyani Aswale (Hyderabad / IN)
Metabolism, Biochemistry & Drug Development
Poster presentation
P103
Recurrent ocular toxoplasmosis after SARS-CoV-2 infection: three case reports
Dr. Olivera Lijeskić (Belgrade / RS)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P105
Molecular evidence of Toxoplasma gondii infection, neuropathology and immunofluorescent detection in the amygdala, hippocampus, pre-frontal cortex, and occipital areas from forensic human brain tissue from suicide, traffic accidents, and homicide victims.
Dr. Jennifer Nessim (Cali / CO)
Host-Parasite Interaction & Signalling
Poster presentation
P107
AP2 transcription factors involved in the stage progression of Toxoplasma gondii in the cat intestine
Dr. Chandra Ramakrishnan (Zurich / CH)
Stage Conversion & Developmental Biology
Poster presentation
P109
GET-TOXO Project (Spanish Working Group on Toxoplasmosis): a multidisciplinary "One health" approach for controlling toxoplasmosis in human and animals in Spain
Professor Ana Montoya Matute (Madrid / ES)
Epidemiology, Public Health and Clinical Aspects of Toxoplasmosis
Poster presentation
P111
Humoral immunity to Toxoplasma gondii is mediated by the expression of Nfkbid in T cells
Dr. Juan Sanchez-Arcila (Merced / US)
Immunology of Acute & Chronic Infection
Poster presentation
P113
Chronic Toxoplasma gondii Infection Results in Elevated Matrix Metalloproteinase-9 and Reduced Cerebellar Perineuronal Nets
Jianchun Xiao (Baltimore / US)
Host-Parasite Interaction & Signalling
Poster presentation
P115
From TgO/GABA-AT, GABA, and T-263 Mutant to Conception of Toxoplasma
Professor Rima McLeod (Chicago / US)
Stage Conversion & Developmental Biology
Poster presentation
P117
Dissecting the mechanism by which Toxoplasma gondii-specific CD8+ T cells differentiate to become IFNγ producers
Laura Lopez (Merced / US)
Innate Immunity and Immune Evasion
Poster presentation
P119
Unraveling the biochemical interactions that regulate Toxoplasma GRA trafficking
Elisia Paiz (Dallas / US)
Host-Parasite Interaction & Signalling
Poster presentation
P121
In Vitro Activity of Fractionated Methanoic Blueberry Extract against Toxoplasma gondii growth
Japhet Senyo Kamasah (Montgomery / US)
Metabolism, Biochemistry & Drug Development
Poster presentation
P123
Populations of inflammation driven neuroprotective lipocalin-2 reactive mouse astrocytes resolve following chronic Toxoplasma infection.
Emma Wilson (Riverside / US)
Immunology of Acute & Chronic Infection